GENE ONLINE|News &
Opinion
Blog

2021-03-26| SpecialStartups

10 Top Gene Therapy Companies in 2021

by Ruchi Jhonsa
Share To
Three years ago, the FDA granted landmark approval to the first in vivo gene therapy for treating an inherited eye disease. Luxturna, an AAV2 based gene therapy developed by Spark Therapeutics, bagged regulatory win to treat this eye disease called Leber congenital amaurosis. Since then, the agency has approved Zolgensma, a spinal muscular atrophy treatment, and has given green light to dozens of small and big biotechs to start clinical trials for their gene therapies.

GO Prime with only $1.49 now

LATEST
China’s Hengrui Buds Off New Biotech With 11 Oncology Programs
2022-05-19
Pfizer to Address COVID-19 Reinfection After Treated by Paxlovid
2022-05-19
Kelun Pharmaceuticals to Receive Up To $1.4 Billion From Merck in Lowkey Deal
2022-05-19
FDA Allows Resumption of Gilead’s Lenacapavir AIDS Trials
2022-05-19
RNA Therapeutics Beyond Vaccines
2022-05-19
Overcoming Aging Related Hearing Loss- A Possibility In The Not So Distant Future
2022-05-18
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding
2022-05-18
EVENT
2022-05-17
The Future Of Everything Festival 2022
New York / Online
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!